全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

污水处理中几种去除药物及个人护理用品方法的机理及效果比较

Keywords: 药物及个人护理品,传统活性污泥,膜生物反应器,高级氧化,污水处理

Full-Text   Cite this paper   Add to My Lib

Abstract:

目前广泛分布在环境中的药物及个人护理品(pharmaceuticalsandpersonalcareproducts,PPCPs)在环境中的迁移、转化和处理已成为环境科学与工程研究的一个新的领域。污水处理厂排水是PPCPs进入环境中的主要途径。介绍了污水处理过程中传统活性污泥法、膜处理技术以及氧化处理等主要工艺对PPCPs的去除机理,并对去除效果进行了比较。以传统活性污泥法及在其改进后的膜处理技术为基础的大部分现有污水处理厂只能够去除一部分PPCPs,并且主要通过吸附(如对于吐纳麝香、佳乐麝香、萨利麝香等脂溶性较高的有机物)和生物降解作用(如对于布洛芬,17β-雌二醇,雌酮等易反应的有机物)。然而,吸附了PPCPs的污泥通过土壤施肥又将PPCPs带入土壤中,进而会渗滤到地下水,或随径流水进入地表水中。因此,PPCPs并没有从根本上得以去除。相比之下氧化处理工艺(如氯化、臭氧氧化、紫外辐射)或这些工艺的组合能够将大部分的PPCPs进行氧化,去除效果明显优于以上2种技术。然而,氧化后产物的种类和毒理性需要更深入的研究。

References

[1]  Ternes T A,Occurrence of drugs in German sewage treatment plants and rivers,Water Research,1998(11).
[2]  Kolpin D W,Furlong E T,Meyer M T,Pharmaceuticals,hormones,and other organic wastewater contaminants in U.S.streams,1999~2000:A national reconnaissance,Environ Sei Tecbnol,2002.
[3]  Metcalfe C D,Miao X S,Koenig B G,Distrubition of acdic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes,Canada Environmental Toxicology and Chemistry,2003(12).
[4]  Mcardell C S,Molnar E,Marc J F S,Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the glatt valley watershed,Switzerland,Environmental Science and Technology,2003(24).
[5]  Heberer T,Occurrence,fate,and removal of pharmaceutical residues in the aquatic environment:A review of recent research data,Toxicology Letters,2002.
[6]  Fooken C,Gihr R,Seel P,In Orienticrende Messungen gefahrlicher Stoffe-Landesweite Untersuehungen auforganische Spurenverunreinigungen in hessischen Flieβ gewassern,Hessisches Landesamt fur Umwelt:Wiesbaden,Germany,1999.
[7]  Ternes T A,Herrmann N,Bonerz M,A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge,Water Research,2004(19).
[8]  Carballa M,Omil F,Lema J M,Behavior of pharmaceuticals,cosmetics and hormones in a sewage treatment plant,Water Research,2004(12).
[9]  Kreuzinger N,Clara M,Strenn B,Relevance of the sludge retention time(SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater,Water Science and Technology,2004(05).
[10]  Clara M,Kreuzinger N,Strenn B,The solids retention time-A suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants,Water Research,2005(01).
[11]  Andersen H,Siegrist H,Halling-Srensen B,Fate of estrogens in a municipal sewage treatment plant,Environmental Science and Technology,2003(18).
[12]  Joss A,Andersen H,Terries T,Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions:Consequences for plant optimization,Environmental Science and Technology,2004(11).
[13]  Johnson A C,Williams R J,A model to estimate influent and effluent concentrations of estradiol,estrone,and ethinylestradiol at sewage treatment works,Environmental Science and Technology,2004(13).
[14]  Clara M,Strenn B,Gans O,Removal of selected pharmaceuticals,fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants,Water Research,2005(19).
[15]  Glassmeyer S T,Shoemaker J A,Effects of chlorination on the persistence of pharmaceuticals in the environment,Bulletin of Environmental Contamination and Toxicology,2005(01).
[16]  Bedner M,MacCrehan W A,Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine,Environmental Science and Technology,2006(02).
[17]  Korshin G V,Kim J,Gan L,Comparative study of reactions of endocrine disruptors bisphenol A and diethylstilbestrol in electrochemical treatment and chlorination,Water Research,2006(05).
[18]  Dodd M C,Huang C,Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine:Kinetics,mechanisms,and pathways,Environmental Science and Technology,2004(21).
[19]  Canosa P,Rodriguez I,Rubi E,Formation of halogenated by-products of parabens in chlorinated water,Analytica Chimica Acta,2006(01).
[20]  Chamberlain E,Adams C,Oxidation of sulfonamides,macrolides,and carbadox with free chlorine and monochloramine,Water Research,2006(13).
[21]  Deborde M,Rabouan S,Gallard H,Aqueous chlorination kinetics of some endocrine disruptors,Environmental Science and Technology,2004(21).
[22]  Ternes T A,Stuber J,Herrmann N,Ozonation:A tool for removal of pharmaceuticals,contrast media and musk fragrances from wastewater,Water Research,2003(08).
[23]  Zwiener C,Frimmel F H,Oxidative treatment of pharmaceuticals in water,Water Research,2000(06).
[24]  Huber M M,Ternes T A,Gunten U,Removal of estrogenic activity and formation of oxidation products during ozonation of 17-ethinylestradiol,Environmental Science and Technology,2004(19).
[25]  Vogna D,Marotta R,Andreozzi R,Kinetic and chemical assessment of the UV/H_2O_2 treatment of antiepileptie drug carbamazepine,Chemosphere,2004(04).
[26]  Rosenfeldt E J,Chen P J,Kullman S,Destruction of estrogenic activity in water using UV advanced oxidation,Science of the Total Environment,2007(01).
[27]  Rosenfeldt E J,Linden K G,Degradation of endocrine disrupting chemicals bisphenol A,ethinyl estradiol,and estradiol during UV photolysis and advanced oxidation processes,Environmental Science and Technology,2004(20).
[28]  Adams C,Wang Y,Asce M,Removal of antibiotics from surface and distilled water in conventional water treatment processes,Journal of Environmental Engineering,2002(03).
[29]  Huber M M,Gobel A,Joss A,Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents:A pilot study,Environmental Science and Technology,2005(11).
[30]  Alum A,Yoon Y,Westerhoff P,Oxidation of bisphenol A,17-estradiol,and 17-ethynyl estradiol and byproduct estrogenieity,Environmental Toxicology,2004(03).
[31]  Huber M M,Canonica S,Park G,Oxidation of pharmaceuticals during ozonation and advanced oxidation processes,Environmental Science and Technology,2003(05).
[32]  McDowell D C,Huber M M,Wagner M,Ozonation of carbamazepine in drinking water:Identification and kinetic study of major oxidation products,Environmental Science and Technology,2005(20).
[33]  Qiang Z,Macauley J J,Mormile M R,Treatment of antibiotics and antibiotic resistant bacteria in swine wastewater with free chlorine,Journal of Agricultural and Food Chemistry,2006(21).
[34]  Song W,Huang M,Rumbeiha W,Determination of amprolium,carbadox,monensin,and tylosin in surface water by liquid chromatography/tandem mass spectrometry,Rapid Communications in Mass Spectrometry,2007.
[35]  Campagnolo E R,Johnson K R,Karpati A,Antimicrobial residues in animal waste and water resources proximal to large-scale swine and poultry feeding operations,Science of the Total Environment,2002(1-3).
[36]  Wu C,Spongberg A L,Witter J D,Determination of the persistence of pharmaceuticals in biosolids using liquidchromatography tandem mass spectrometry,Chemosphere,2008(04).
[37]  Kasprzyk-Hordern B,Dinsdale R M,Guwy A J,The occurrence of pharmaceuticals,personal care products,endocrine disruptors and illicit drugs in surface water in South Wales,UK Water Research,2008(13).
[38]  Kim S D,Cho J,Kim I S,Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface,drinking,and waste waters,Water Research,2007(05).
[39]  Nikolaou A,Meric S,Fatta D,Occurrence patterns of pharmaceuticals in water and wastewater environments,Analysis and Bioanalysis Chemistry,2007(04).
[40]  Sarmah A K,Meyer M T,Boxall A B A,A global perspective on the use,sales,exposure pathways,occurrence,fate and effects of veterinary antibiotics (VAs) in the environment,Chemosphere,2006(05).
[41]  Boxall A B A,The environmental side effects of medication-How are human and veterinary medicines in soils and water bodies affecting human and environmental health,Embo Reports,2004(12).
[42]  Fent K,Weston A A,Caminada D,Ecotoxieology of human pharmaceuticals,Aquatic Toxicology,2006(02).
[43]  Suarez S,Carballa M,Omil F,How are pharmaceutical and personal care products(PPCPs) removed from urban wastewaters,Reviews in Environmental Science and 8iotechnology,2008(02).
[44]  Reif R,Suarez S,Omil F,Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage,Desalination,2008(1-3).
[45]  Radjenovic J,Petrovic M,Barcelo D,Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor,Analytical and Bioanalytical Chemistry,2007(04).
[46]  Huber M M,Korhonen S,Ternes T A,Oxidation of pharmaceuticals during water treatment with chlorine dioxide,Water Research,2005(15).
[47]  Gobel A,McArdell C S,Joss A,Fate of sulfonamides,maerolides,and trimethoprim in different wastewater treatment technologies,Science of the Total Environment,2007(02).
[48]  Westerhoff P,Yoon Y,Snyder S,Fate of endocrine disruptor,pharmaceutical,and personal care product chemicals during simulated drinking water treatment processes,Environmental Science and Technology,2005(17).
[49]  Gibs J,Stackelberg P E,Furlong E T,Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time,Science of the Total Environment,2007(01).
[50]  Boyd G R,Zhang S,Grimm D A,Naproxen removal from water by chlorination and biofilm processes,Water Research,2005(04).

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133